Biotechnology

Exploring Bittensor and Its Impact on Drug Discovery

Bittensor is revolutionizing drug discovery through decentralized networks, cutting costs and streamlining processes for innovative solutions.

Exploring the Future of Longevity and Brain-Computer Interfaces

Exploring advancements in longevity, brain-computer interfaces, and vision restoration technologies shaping the future of healthcare.

Revolutionizing Chemical Manufacturing with Enzymatic Processes

Solugen innovates chemical manufacturing by combining biology and chemistry for efficiency, transforming production methods and challenging traditional beliefs.

Revolutionizing Aging: The Future of Age Reversal Research

Recent research indicates the possibility of reversing aging, paving the way for extended lifespans and groundbreaking health advancements.

Roche's Strategic AI Investment Revolutionizes Drug Development

Roche's deployment of 3,500 Nvidia GPUs demonstrates a bold move to enhance drug development through AI, targeting key therapeutic markets.

Alto Neuroscience Secures $120 Million for Depression Treatment Development

Alto Neuroscience raises $120 million to advance ALTO-207, a treatment for resistant depression, boosting investor confidence.

Thrive Capital Raises $10 Billion for Innovative Investments

Thrive Capital's new fund exceeds $10 billion, targeting investments in AI, robotics, and life sciences, marking a major growth initiative.

Microsoft and Bristol Myers Squibb Partner to Enhance Lung Cancer Detection

Microsoft partners with Bristol Myers Squibb to use AI for early lung cancer detection, targeting underserved areas for better healthcare access.

NVIDIA and Eli Lilly Launch AI Co-Innovation Lab to Transform Drug Discovery

NVIDIA and Lilly are launching an AI lab to redefine drug discovery, with a commitment of up to $1B over five years.

3D Systems Secures FDA Clearance Amid Financial Pressures

Abivax (ABVX): Q3 2025 Financial Results and Trial Updates

Enlivex Therapeutics Initiates Innovative Digital Asset Treasury Strategy

Enlivex Therapeutics invests $212 million into a RAIN-based digital asset treasury, doubling the token’s value and marking a pioneering move.

ARK Invest Adjusts Portfolio by Selling Palantir Shares for Crypto and Biotech Investments

ARK Invest sold over 38,000 Palantir shares, reallocating funds to crypto and biotech, reflecting a strategy to balance its investment portfolio.

Latest IPOs and Secondary Offerings You Should Know

Several companies are entering the IPO and secondary offering market, reflecting investor interest and growth funding opportunities.

YZi Labs Launches $1 Billion Builder Fund to Ignite Innovation in the BNB Ecosystem

YZi Labs has launched a $1 billion Builder Fund to support innovation in the BNB ecosystem focusing on Web3, AI, and biotech projects.